Literature DB >> 32132029

Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.

Virinder Sarhadi1, Leo Lahti2, Farideh Saberi3, Omar Youssef1, Arto Kokkola4, Tiina Karla5, Milja Tikkanen5, Hilpi Rautelin6, Pauli Puolakkainen5, Rasoul Salehi3,7, Sakari Knuutila8.   

Abstract

BACKGROUND/AIM: Gut microbiota plays an important role in colorectal cancer (CRC) and its composition in CRC patients can be influenced by ethnicity and tumour genomics. Herein, the aim was to study the possible associations of ethnicity and gene mutations with the gut microbiota in CRC patients.
MATERIALS AND METHODS: Bacterial composition in stool samples of 83 CRC patients and 60 controls from Iran and Finland was studied by 16S rRNA gene sequencing. The association of gut microbiota composition with CRC, host mutations in KRAS, NRAS and TP53, and ethnicity analysed.
RESULTS: Beta diversity analysis indicated significant differences between the Iranian and Finnish gut microbiota composition, in both controls and patients' groups. The Iranian controls had higher abundance of Prevotella and lower abundance of Bacteroides compared to the Finnish controls, while the Finnish patients had higher abundance of Clostridium compared to Iranian patients. Abundance of Ruminococcus was higher in patients compared to the controls. Higher abundances of Herbaspirillum, Catenibacterium and lower abundances of Barnesiella were associated with mutations in NRAS, TP53, and RAS respectively.
CONCLUSION: A possible link of host gene mutations with gut bacterial composition is suggested. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  16S rRNA gene sequencing; Gut microbiota; colorectal cancer; gene mutations; stool DNA

Year:  2020        PMID: 32132029     DOI: 10.21873/anticanres.14074

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review.

Authors:  Maryam Ranjbar; Rasoul Salehi; Shaghayegh Haghjooy Javanmard; Laleh Rafiee; Habibollah Faraji; Sima Jafarpor; Gordon A Ferns; Majid Ghayour-Mobarhan; Mostafa Manian; Reza Nedaeinia
Journal:  Cancer Cell Int       Date:  2021-04-06       Impact factor: 6.429

Review 2.  Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients.

Authors:  Heidelinde Sammallahti; Arto Kokkola; Sama Rezasoltani; Reza Ghanbari; Hamid Asadzadeh Aghdaei; Sakari Knuutila; Pauli Puolakkainen; Virinder Kaur Sarhadi
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

3.  The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma.

Authors:  Sofie Bosch; Animesh Acharjee; Mohammed N Quraishi; Patricia Rojas; Abdellatif Bakkali; Erwin Ew Jansen; Marina Brizzio Brentar; Johan Kuijvenhoven; Pieter Stokkers; Eduard Struys; Andrew D Beggs; Georgios V Gkoutos; Tim Gj de Meij; Nanne Kh de Boer
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  A systematic review of microbial markers for risk prediction of colorectal neoplasia.

Authors:  Lili Yu; Gang Zhao; Lijuan Wang; Xuan Zhou; Jing Sun; Xinxuan Li; Yingshuang Zhu; Yazhou He; Kleovoulos Kofonikolas; Debby Bogaert; Malcolm Dunlop; Yimin Zhu; Evropi Theodoratou; Xue Li
Journal:  Br J Cancer       Date:  2022-03-15       Impact factor: 9.075

Review 5.  Molecular Biomarkers in Cancer.

Authors:  Virinder Kaur Sarhadi; Gemma Armengol
Journal:  Biomolecules       Date:  2022-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.